Journalartikel

Systemic sclerosis: state of the art on clinical practice guidelines


AutorenlisteSmith, Vanessa; Scire, Carlo Alberto; Talarico, Rosaria; Airo, Paolo; Alexander, Tobias; Allanore, Yannick; Bruni, Cosimo; Codullo, Veronica; Dalm, Virgil; De Vries-Bouwstra, Jeska; Della Rossa, Alessandra; Distler, Oliver; Galetti, Ilaria; Launay, David; Lepri, Gemma; Mathian, Alexis; Mouthon, Luc; Ruaro, Barbara; Sulli, Alberto; Tincani, Angela; Vandecasteele, Els; Vanhaecke, Amber; Vanthuyne, Marie; Van den Hoogen, Frank; Van Vollenhoven, Ronald; Voskuyl, Alexandre E.; Zanatta, Elisabetta; Bombardieri, Stefano; Burmester, Gerd; Eurico, Fonseca Joao; Frank, Charissa; Hachulla, Eric; Houssiau, Frederic; Mueller-Ladner, Ulf; Schneider, Matthias; van Laar, Jacob M.; Vieira, Ana; Cutolo, Maurizio; Mosca, Marta; Matucci-Cerinic, Marco

Jahr der Veröffentlichung2018

ZeitschriftRMD Open: Rheumatic and Musculoskeletal Diseases

Bandnummer4

ISSN2056-5933

DOI Linkhttps://doi.org/10.1136/rmdopen-2018-000782

VerlagBMJ Publishing Group


Abstract
Systemic sclerosis (SSc) is an orphan disease characterised by autoimmunity, fibrosis of the skin and internal organs, and vasculopathy. SSc may be associated with high morbidity and mortality. In this narrative review we summarise the results of a systematic literature research, which was performed as part of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases project, aimed at evaluating existing clinical practice guidelines or recommendations. Only in the domains 'Vascular & Ulcers' (ie, non-pharmacological approach to digital ulcer), 'PAH' (ie, screening and treatment), 'Treatment' and 'Juveniles' (ie, evaluation of juveniles with Raynaud's phenomenon) evidence-based and consensus-based guidelines could be included. Hence there is a preponderance of unmet needs in SSc referring to the diagnosis and (non-) pharmacological treatment of several SSc-specific complications. Patients with SSc experience significant uncertainty concerning SSc-related taxonomy, management (both pharmacological and non-pharmacological) and education. Day-to-day impact of the disease (loss of self-esteem, fatigue, sexual dysfunction, and occupational, nutritional and relational problems) is underestimated and needs evaluation.



Zitierstile

Harvard-ZitierstilSmith, V., Scire, C., Talarico, R., Airo, P., Alexander, T., Allanore, Y., et al. (2018) Systemic sclerosis: state of the art on clinical practice guidelines, RMD OPEN, 4, Article UNSP e000782. https://doi.org/10.1136/rmdopen-2018-000782

APA-ZitierstilSmith, V., Scire, C., Talarico, R., Airo, P., Alexander, T., Allanore, Y., Bruni, C., Codullo, V., Dalm, V., De Vries-Bouwstra, J., Della Rossa, A., Distler, O., Galetti, I., Launay, D., Lepri, G., Mathian, A., Mouthon, L., Ruaro, B., Sulli, A., ...Matucci-Cerinic, M. (2018). Systemic sclerosis: state of the art on clinical practice guidelines. RMD OPEN. 4, Article UNSP e000782. https://doi.org/10.1136/rmdopen-2018-000782



Schlagwörter


DEVELOPING CRITERIAEXPERT CONSENSUSFUNCTIONAL DISABILITYINTERSTITIAL LUNG-DISEASEPRACTICE PATHWAYRECOMMENDATIONSSIMPLE CAPILLAROSCOPIC DEFINITIONSSKIN ULCERSSTEM-CELL TRANSPLANTATION


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-02-04 um 01:10